Skip to main content

Table 4 Anti-Tat Ab response by Ig subclasses in vaccinees and placebos

From: HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

 

Vaccinees (n = 99)

Placebos (n = 100)

n

%

n

%

IgM+

1

1.0

5

5.0

IgG+

9

9.1

5

5.0

IgA+

0

0.0

2

2.0

IgM + IgG+

11

11.1

4

4.0

IgM + IgA+

0

0.0

0

0.0

IgG + IgA+

7

7.1

3

3.0

IgM + IgG + IgA+

68

68.7

1

1.0

Ab-negative

3

3.0

80

80.0

  1. Percentage of subjects positive for 1, 2 or 3 anti-Tat Ab subclasses at any given time point after the first immunization
  2. n number of subjects
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us